Key result
Combined inhibition of nitric oxide and prostaglandins modestly reduced steady-state ATP-mediated vasodilation (P<0.05), indicating the majority of this vasodilation is independent of these pathways.
Why the study?
Does inhibition of nitric oxide synthase and cyclooxygenase alter ATP-mediated vasodilation in young, healthy humans?
Does inhibition of nitric oxide synthase and cyclooxygenase alter ATP-mediated vasodilation in young, healthy humans?
p-value: p=<0.05
Nitric oxide and vasodilating prostaglandins play only a modest role in ATP-mediated vasodilation in the human forearm, with the majority of the response being independent of these pathways.
Limited roles in healthy adults warrant no clinical adjustment; leaves open contributions in aging or disease.
ATP is an endothelium-dependent vasodilator, and findings regarding the underlying signaling mechanisms are equivocal. We sought to determine the independent and interactive roles of nitric oxide (NO) and vasodilating prostaglandins (PGs) in ATP-mediated vasodilation in young, healthy humans and determine whether any potential role was dependent on ATP dose or the timing of inhibition. In protocol 1 (n = 18), a dose-response curve to intrabrachial infusion of ATP was performed before and after both single and combined inhibition of NO synthase [N(G)-monomethyl-L-arginine (L-NMMA)] and cyclooxygenase (ketorolac). Forearm blood flow (FBF) was measured via venous occlusion plethysmography and forearm vascular conductance (FVC) was calculated. In this protocol, neither individual nor combined NO/PG inhibition had any effect on the vasodilatory response (P = 0.22-0.99). In protocol 2 (n = 16), we determined whether any possible contribution of both NO and PGs to ATP vasodilation was greater at low vs. high doses of ATP and whether inhibition during steady-state infusion of the respective dose of ATP impacted the dilation. FBF in this protocol was measured via Doppler ultrasound. In protocol 2, infusion of low (n = 8)- and high-dose (n = 8) ATP for 5 min evoked a significant increase in FVC above baseline (low = 198 ± 24%; high = 706 ± 79%). Infusion of L-NMMA and ketorolac together reduced steady-state FVC during both low- and high-dose ATP (P < 0.05), and in a subsequent trial with continuous NO/PG blockade, the vasodilator response from baseline to 5 min of steady-state infusion was similarly reduced for both low (ΔFVC = -31 ± 11%)- and high-dose ATP (ΔFVC -25 ± 11%; P = 0.70 low vs. high dose). Collectively, our findings indicate a potential modest role for NO and PGs in the vasodilatory response to exogenous ATP in the human forearm that does not appear to be dose or timing dependent; however, this is dependent on the method for assessing forearm vascular responses. Importantly, the majority of ATP-mediated vasodilation is independent of these putative endothelium-dependent pathways in humans.
No takes yet. Share an insight, caveat, or question.
Crecelius et al. (2011) studied Healthy (n=34). Nitric oxide synthase and cyclooxygenase inhibition (L-NMMA and ketorolac) vs. Baseline / before inhibition was evaluated on Forearm vascular conductance (FVC) response to ATP (p=<0.05). Combined inhibition of nitric oxide and prostaglandins modestly reduced steady-state ATP-mediated vasodilation (P<0.05), indicating the majority of this vasodilation is independent of these pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: